XERS — Xeris Biopharma Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Xeris Biopharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	134	102	122	72.5	71.6
Net Total Accounts Receivable
Net Total Receivables	6.88	17.5	30.8	39.2	40.4
Total Inventory
Prepaid Expenses
Total Current Assets	152	143	187	156	168
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.71	6.63	9.51	29.2	28.2
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	159	304	345	323	323
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.2	79	73.6	95.2	100
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	125	209	299	329	353
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	33.8	95.2	45.2	-6.78	-29.6
Total Liabilities & Shareholders' Equity	159	304	345	323	323
Total Common Shares Outstanding